JENNIFER L. BALL DO NPI 1386635548

NPI Details

Jennifer L. Ball, DO is a medical oncology internal medicine in Clearwater, FL with 33 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Jennifer L. Ball, DO NPI is 1386635548. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE
Graduation Year:1993

The provider's business location address is:

3280 N MCMULLEN BOOTH RD
SUITE 200
CLEARWATER, FL
ZIP 33761-029
Phone: (727) 216-1141
Fax: (727) 796-6459

The NPI 1386635548 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Protein measurement, serum (HCPCS:84165)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Magnesium level (HCPCS:83735)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Drawing of blood for a medical problem (HCPCS:99195)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Red blood count automated, with additional calculations (HCPCS:85046)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Automated urinalysis test (HCPCS:81003)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Erythropoietin (protein) level (HCPCS:82668)
• Red blood count, manual test (HCPCS:85044)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 11/4/2005 and was last updated on 8/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.